Local research into stroke has been given a significant boost thanks to the donation of a cutting-edge machine to the University of Malta.

The fully automated EVOS®FL Auto Imaging System is a cell imaging device that will make it easier for researchers to use high-end microscopic images. 

Cell imaging is used by scientists to obtain a better understanding of biological function through the study of cellular dynamics.

The machine donated to the University integrates technologies such as time-lapse imaging, multiwell plate scanning, image stitching and tiling, and cell counting. It comes complete with an onboard computer, innovative LED light source, filters and an array of objectives that have been selected to meet the requirements of the University’s Stroke Research Group.

The system was donated to the University by healthcare and laboratory equipment provider E.J. Busuttil Limited. The University’s research trust (RIDT) facilitated the donation.

Stroke Research Group head Mario Valentino thanked E.J. Busuttil for the generosity.

“This tool will provide us with high-quality imaging, easier than ever before. The ground-breaking design with integrated hardware/software, no bulbs, no alignment, no on-going costs or maintenance, will be very beneficial to our research team who is working on a very tight budget,” said Prof. Valentino.

E.J. Busuttil managing director Edwin Busuttil said the company was committed to improving the quality of life of the Maltese community.

“Being of great assistance to the University of Malta, in its mission on stroke research, is another practical way how we can help,” he said.

RIDT was set up to strengthen investment in high-calibre research and development across every faculty and to attract the necessary funds. Further information can be obtained from www.ridt.eu

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.